{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:54:43Z","timestamp":1793040883670,"version":"4.5.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.farma.2024.05.013","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T01:07:29Z","timestamp":1718932049000},"page":"94-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the neuroprotective effect of antipsychotics by serum quantification of protein S100B"],"prefix":"10.1016","volume":"49","author":[{"given":"Jos\u00e9 D.","family":"Santotoribio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Ca\u00f1avate-Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Corral-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"O'Ferrall-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.farma.2024.05.013_bb0005","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s12035-016-9904-4","article-title":"The Atypical Antipsychotic Agent, Clozapine, Protects Against Corticosterone-Induced Death of PC12 Cells by Regulating the Akt\/FoxO3a Signaling Pathway","volume":"54","author":"Zeng","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.farma.2024.05.013_bb0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clinbiochem.2019.08.013","article-title":"Neuroapoptosis in newborns with respiratory acidosis at birth","volume":"74","author":"Santotoribio","year":"2019","journal-title":"Clin Biochem"},{"issue":"4","key":"10.1016\/j.farma.2024.05.013_bb0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.medcli.2016.10.039","article-title":"Neuroprotective effect of sevoflurane in general anaesthesia","volume":"148","author":"Ramos Ramos","year":"2017","journal-title":"Med Clin (Barc)"},{"issue":"9","key":"10.1016\/j.farma.2024.05.013_bb0020","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.medcli.2016.01.018","article-title":"Brain damage after general anesthesia","volume":"146","author":"Mesa Su\u00e1rez","year":"2016","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.farma.2024.05.013_bb0025","doi-asserted-by":"crossref","unstructured":"Donato R, Heizmann CW. S100B Protein in the Nervous System and Cardiovascular Apparatus in Normal and Pathological Conditions. Cardiovasc Psychiatry Neurol 2010;2010:929712. doi: 10.1155\/2010\/929712.","DOI":"10.1155\/2010\/929712"},{"key":"10.1016\/j.farma.2024.05.013_bb0030","doi-asserted-by":"crossref","unstructured":"Santotoribio JD, Parodi Fern\u00e1ndez V, Mesa Su\u00e1rez P. Sedation with midazolam without neurotoxic effects. Med Clin (Barc). 2018;150(11):450. doi: 10.1016\/j.medcli.2017.10.029.","DOI":"10.1016\/j.medcle.2017.10.049"},{"key":"10.1016\/j.farma.2024.05.013_bb0035","doi-asserted-by":"crossref","unstructured":"Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, Blasig IE. Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia \u2014 Original research and meta-analysis. Psychiatry Res 2009;167(1\u20132):66\u201372. doi: 10.1016\/j.psychres.2008.01.002.","DOI":"10.1016\/j.psychres.2008.01.002"},{"key":"10.1016\/j.farma.2024.05.013_bb0040","doi-asserted-by":"crossref","unstructured":"Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull 1987;13(2):261\u201376. doi:10.1093\/schbul\/13.2.261.","DOI":"10.1093\/schbul\/13.2.261"},{"key":"10.1016\/j.farma.2024.05.013_bb0045","doi-asserted-by":"crossref","unstructured":"Gil D, Bengochea R, Arrieta M, Fern\u00e1ndez M, \u00c1lvarez A, S\u00e1nchez R, et al. Validez del factor cognitivo de la PANSS como medida del rendimiento cognitivo en esquizofrenia. Rev Psiquiatr Salud Ment 2009;2(4):160\u20138. doi: 10.1016\/S1888-9891(09)73234-3.","DOI":"10.1016\/S1888-9891(09)73234-3"},{"issue":"2","key":"10.1016\/j.farma.2024.05.013_bb0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.24869\/psyd.2021.158","article-title":"Oxidative Stress and Serum S100B Levels in Adolescents with First-Episode Drug-Naive Unipolar Depression","volume":"33","author":"Bilginer","year":"2021","journal-title":"Psychiatr Danub"},{"key":"10.1016\/j.farma.2024.05.013_bb0055","doi-asserted-by":"crossref","unstructured":"Sch\u00fcmberg K, Polyakova M, Steiner J, Schroeter ML. Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia\u2014A Meta-Regression Analysis. Front Cell Neurosci 2016;(10):46. doi: 10.3389\/fncel.2016.00046.","DOI":"10.3389\/fncel.2016.00046"},{"key":"10.1016\/j.farma.2024.05.013_bb0060","doi-asserted-by":"crossref","unstructured":"Steiner J, Bernstein HG, Bogerts B, Gos T, Richter-Landsberg C, Wunderlich MT, et al. S100B is expressed in, and released from, OLN-93 oligodendrocytes: Influence of serum and glucose deprivation. Neuroscience. 2008;154(2):496\u2013503. doi: 10.1016\/j.neuroscience.2008.03.060.","DOI":"10.1016\/j.neuroscience.2008.03.060"},{"key":"10.1016\/j.farma.2024.05.013_bb0065","doi-asserted-by":"crossref","unstructured":"Hong W, Zhao M, Li H, Peng F, Wang F, Li N, et al. Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers. Sci Rep 2016;6:27584. doi: 10.1038\/srep27584.","DOI":"10.1038\/srep27584"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S113063432400093X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S113063432400093X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:09:39Z","timestamp":1750136979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S113063432400093X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S113063432400093X"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2024.05.013","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the neuroprotective effect of antipsychotics by serum quantification of protein S100B","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2024.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}